Intrinsic Value of S&P & Nasdaq Contact Us

Mallinckrodt plc MNKPF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • IE • USD

SharesGrow Score
62/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Mallinckrodt plc (MNKPF) trades at a trailing P/E of 0.7. Trailing earnings yield is 140.85%.

Criteria proven by this page:

  • VALUE (100/100, Pass) — P/E is below market average (0.7); earnings yield beats bond yields (140.85%).
  • Trailing Earnings Yield 140.85% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.

Overall SharesGrow Score: 60/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
62/100
SG Score
View full scorecard →
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
FUTURE
N/A
No coverage
PAST
25/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
~
MOAT
55/100
→ Income
~
GROWTH
58/100
→ Income
INCOME
85/100
→ Income

Valuation Snapshot — MNKPF

Valuation Multiples
P/E (TTM)0.7
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.17
EV/EBITDA0.0
Per Share Data
EPS (TTM)$24.14
Book Value / Share$0.00
Revenue / Share$99.98
FCF / Share$0.00
Yields & Fair Value
Earnings Yield140.85%
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2014 $-4.92 $2.54B $-319.3M -12.6%
2015 $2.75 $3.35B $324.7M 9.7%
2016 $5.77 $3.38B $643.7M 19%
2017 $21.80 $3.22B $2.13B 66.3%
2018 $-42.94 $3.22B $-3.61B -112.2%
2019 $-12.00 $3.16B $-1.01B -31.8%
2020 $-11.48 $2.21B $-969.7M -43.8%
2021 $-8.54 $2.21B $-723.5M -32.8%
2022 $-8.47 $2.21B $-717.4M -32.5%
2024 $24.14 $1.98B $477.9M 24.1%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message